Curanex Pharmaceuticals (CURX) vs InMed Pharmaceuticals (INM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
InMed Pharmaceuticals is the larger company by market cap ($7.6 million vs $7.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CURX | INM |
|---|---|---|
| Share price | $4.61 | $1.39 |
| Market cap | $7.23M | $7.64M |
| 1-day change | -3.15% | +4.51% |
| EPS (TTM) | $-7.80 | $-2.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.94 | $2.40 |
| 52-week low | $3.58 | $0.575 |
| Distance from 52-week high | -72.79% | -42.08% |
| Average volume | 19.85K | 914.23K |
| Shares outstanding | 1.57M | 5.49M |
| Employees | 6 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Curanex Pharmaceuticals
CURX stock →Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About InMed Pharmaceuticals
INM stock →InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
CURX vs INM FAQ
Which is bigger, Curanex Pharmaceuticals or InMed Pharmaceuticals?
InMed Pharmaceuticals (INM) is larger, with a market capitalization of $7.64M compared with $7.23M for Curanex Pharmaceuticals (CURX).
Are Curanex Pharmaceuticals and InMed Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.